Heterozygous pathogenic STT3A variation leads to dominant congenital glycosylation disorders and functional validation in zebrafish
Authors:
Open Access
- 31 January 2025
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 20 (1) , 1-14
Abstract
Background: Congenital disorders of glycosylation are a rare group of disorders characterized by impaired glycosylation, wherein STT3A encodes the catalytic subunit of the oligosaccharyltransferase complex, which is crucial for protein N-glycosylation. Previous studies have reported that STT3A-CDG is caused by autosomal recessive inheritance. However, in this study, we propose that STT3A-CDG can be pathogenic through autosomal dominant inheritance. Methods: The variant was identified via trio whole-exome sequencing. We constructed wild-type and variant plasmids, transfected them into HEK293T cells and detected the expression levels of the STT3A protein. We performed CRISPR-Cas9 to establish heterozygous knockdown zebrafish to validate the functional implications of autosomal dominant inheritance of STT3A in pathogenesis. Results: The patient presented with developmental delay, distinctive facial features, short stature, and abnormal discharges. The heterozygous pathogenic missense variant (NM_001278503.2: c.499G > T, NP_001265432.1:p. Asp167Tyr) was identified, and the Western blot results revealed a significant decrease in protein levels. Heterozygous knockdown zebrafish exhibit phenotypes similar to those of patients, including craniofacial dysmorphology (increased eye distance, increased Basihyal’s length, increased Ceratohyal’s angle), skeletal abnormalities (reduced number of mineralized bones), developmental delay (reduced adaptability under light‒dark stimuli suggesting abnormal locomotion, orientation, and social behavior), and electrophysiological abnormalities. Conclusion: We report a proband with a dominant congenital glycosylation disorder caused by heterozygous pathogenic STT3A variation, which is a new inheritance pattern of STT3A. Our report expands the known phenotype of dominant STT3A-CDGs. Furthermore, we provide in vivo validation through the establishment of a heterozygous knockdown zebrafish model for stt3a and strengthened the compelling evidence for dominant STT3A-related pathogenesis.Keywords
Funding Information
- Chongqing Municipal Science and Health Joint Medical Research Middle and Young Medical High-end Talent Project (2024GDRC015)
This publication has 25 references indexed in Scilit:
- ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECAEuropean Journal of Pediatrics, 2022
- Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findingsThe American Journal of Human Genetics, 2021
- Congenital disorders of glycosylation: Still “hot” in 2020Biochimica et Biophysica Acta (BBA) - General Subjects, 2021
- Perspectives on Glycosylation and Its Congenital DisordersTrends in Genetics, 2018
- High Rate of Recurrent De Novo Mutations in Developmental and Epileptic EncephalopathiesThe American Journal of Human Genetics, 2017
- What is new in CDG?Journal of Inherited Metabolic Disease, 2017
- Homozygous single base deletion in TUSC3 causes intellectual disability with developmental delay in an Omani familyAmerican Journal of Medical Genetics Part A, 2016
- CDG nomenclature: Time for a change!Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Cotranslational and Posttranslational N-Glycosylation of Polypeptides by Distinct Mammalian OST IsoformsCell, 2009
- Analysis of Upstream Elements in the HuC Promoter Leads to the Establishment of Transgenic Zebrafish with Fluorescent NeuronsDevelopmental Biology, 2000